LASEA Ísrael - enska - Ministry of Health

lasea

dr.samuelov importing & marketing ltd, israel - lavender oil - capsules soft - lavender oil 80 mg - treatment of anxiety in adults.

GAMMADERM 200MG/G CREAM Írland - enska - HPRA (Health Products Regulatory Authority)

gammaderm 200mg/g cream

dr. august wolff gmbh & co. - oenothera biennis - cream - 200 mg/g

Dr Reddy's Omeprazole 10mg Nýja-Sjáland - enska - Medsafe (Medicines Safety Authority)

dr reddy's omeprazole 10mg

dr reddy's new zealand limited - omeprazole 10mg;   - modified release capsule - 10 mg - active: omeprazole 10mg   excipient: capsugel purple op.c046 capsugel yellow op.c305 crospovidone hypromellose isopropyl alcohol magnesium stearate mannitol meglumine methacrylic acid - ethyl acrylate copolymer opacode black s-1-27794 poloxamer povidone purified water triethyl citrate

Dr Reddy's Sertraline Nýja-Sjáland - enska - Medsafe (Medicines Safety Authority)

dr reddy's sertraline

dr reddy's new zealand limited - sertraline hydrochloride 111.92mg equivalent to sertraline 100 mg - film coated tablet - 100 mg - active: sertraline hydrochloride 111.92mg equivalent to sertraline 100 mg excipient: calcium hydrogen phosphate colloidal silicon dioxide hyprolose magnesium stearate microcrystalline cellulose opadry white oy-58900 polysorbate 80 sodium starch glycolate - sertraline is indicated for the treatment of symptoms of depression, including depression accompanied by symptoms of anxiety, in patients with or without a history of mania. following satisfactory response, continuation with sertraline therapy is effective in preventing relapse of the initial episode of depression or recurrence of further depressive episodes.

Dr Reddy's Sertraline Nýja-Sjáland - enska - Medsafe (Medicines Safety Authority)

dr reddy's sertraline

dr reddy's new zealand limited - sertraline hydrochloride 55.96mg equivalent to sertraline 50 mg - film coated tablet - 50 mg - active: sertraline hydrochloride 55.96mg equivalent to sertraline 50 mg excipient: calcium hydrogen phosphate colloidal silicon dioxide hyprolose magnesium stearate microcrystalline cellulose opadry white oy-58900 polysorbate 80 sodium starch glycolate - sertraline is indicated for the treatment of symptoms of depression, including depression accompanied by symptoms of anxiety, in patients with or without a history of mania. following satisfactory response, continuation with sertraline therapy is effective in preventing relapse of the initial episode of depression or recurrence of further depressive episodes.

Salofalk 1.5g prolonged-release granules Írland - enska - HPRA (Health Products Regulatory Authority)

salofalk 1.5g prolonged-release granules

dr. falk pharma gmbh - mesalazine - prolonged-release granules - 1.5 gram(s) - aminosalicylic acid and similar agents; mesalazine

Salofalk 1g Suppositories Írland - enska - HPRA (Health Products Regulatory Authority)

salofalk 1g suppositories

dr. falk pharma gmbh - mesalazine - suppository - 1 gram(s) - aminosalicylic acid and similar agents; mesalazine

Salofalk 1000mg prolonged-release granules Írland - enska - HPRA (Health Products Regulatory Authority)

salofalk 1000mg prolonged-release granules

dr. falk pharma gmbh - mesalazine - prolonged-release granules - 1000 milligram(s) - aminosalicylic acid and similar agents; mesalazine

Salofalk 500 mg prolonged-release granules Írland - enska - HPRA (Health Products Regulatory Authority)

salofalk 500 mg prolonged-release granules

dr. falk pharma gmbh - mesalazine - prolonged-release granules - 500 milligram(s) - aminosalicylic acid and similar agents; mesalazine